Clinical Trial Update: A Study of Oraxol in Subjects With Cutaneous Angiosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Oraxol in subjects with cutaneous angiosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma of Skin
• Cutaneous Angiosarcoma

Drugs mentioned

• Oraxol

Snippet

Sponsor: Athenex, Inc. | Conditions: Angiosarcoma of Skin | Phase 2 | Status: COMPLETED